Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)
Clinical trial NCT02649361 · COMPLETED
Trial details
- NCT number
- NCT02649361
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2018-07-23
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.